14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.612 16 days ( 20.74 % )
Last Price $43.98 0.549 %
High/ Low $42.08 - $44.76 -0.86%
Chg 7 Days -2.63 % $45.17 $43.98
Chg 30 Days -23.14 % $57.22 $43.98
Chg 12 mos -33.00 % $65.64 $43.98
Trend - 3 mos -22.89 % Width: 32.11 %
Trend - 12 mos -21.14 % Width: 52.92 %
Pred. range - 3 mos $33.51 - $44.27 -23.80 % - 0.660 %
Pred. range - 12 mos $34.44 - $52.66 -21.70 % - 19.74 %
Short MA avg 3 mos Buy Apr 08, 2024 - 18 days
Long MA avg 3 mos Sell Mar 19, 2024 - 31 days
Short/Long MA avg 3 mos Sell Mar 21, 2024 - 29 days
Short MA avg 12 mos Sell Mar 14, 2024 - 34 days
Long MA avg 12 mos Sell Mar 19, 2024 - 31 days
Short/Long MA avg 12 mos Sell Apr 04, 2024 - 20 days
Pivot Short Buy Apr 30, 2024 - 2 days
Bollinger Buy Apr 18, 2024 - 10 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Legend Biotech Corporation

Legend Biotech Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refr... LEGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT